多重聚合酶链反应检测免疫功能低下急性呼吸衰竭患者鼻咽病毒
该研究为随机对照试验的预设事后分析,纳入2016年5月至2017年12月32个ICU收治的510例免疫功能低下急性呼吸衰竭患者,鼻咽拭子多重PCR检测23种呼吸道病原体。PCR阳性103例(20.2%),病毒检测阳性102例,其中鼻病毒或肠病毒35.5%、冠状病毒10.9%、流感样病毒52.7%。病毒性肺炎比例随PCR结果显著变化:流感样病毒组50.0%、其他病毒组14.0%、无病毒组3.6%(P < .001)。PCR阳性与阴性组28天死亡率、IMV或两者复合结局无差异(54.9% vs 54.7%;P = .965)。
要点
- 鼻咽多重PCR阳性组与阴性组28天死亡率、IMV或两者复合结局无差异(54.9% vs 54.7%;P = .965)。
- 病毒性肺炎比例随PCR结果显著变化:流感样病毒组50.0%、其他病毒组14.0%、无病毒组3.6%(P < .001)。
- PCR阳性患者中最终诊断病毒性肺炎者占三分之一,流感样病毒阳性者中占一半。
- 预设亚组分析中,异基因造血干细胞移植受者检出流感样病毒与更高的28天死亡率、IMV或两者复合结局相关。
- 510例中PCR阳性103例(20.2%),病毒检出102例:鼻病毒或肠病毒35.5%、冠状病毒10.9%、流感样病毒52.7%。
适用人群与场景
- 免疫功能低下因急性呼吸衰竭入住32个ICU的患者,纳入时间为2016年5月至2017年12月。
- 纳入本随机对照试验的预设事后分析,鼻咽拭子于纳入时采样。
研究设计与关键结果
- 研究设计:随机对照试验的预设事后分析,纳入32个ICU的510例免疫功能低下急性呼吸衰竭患者。
- 鼻咽拭子多重PCR检测23种呼吸道病原体,阳性103例(20.2%),病毒检出102例:鼻病毒或肠病毒35.5%、冠状病毒10.9%、流感样病毒(流感病毒、副流感病毒、呼吸道合胞病毒、人偏肺病毒)52.7%。
- 急性呼吸衰竭病因随PCR结果显著变化,病毒性肺炎比例:流感样病毒组50.0%、其他病毒组14.0%、无病毒组3.6%(P < .001)。
- PCR阳性与阴性组28天死亡率、IMV或两者复合结局无差异(54.9% vs 54.7%;P = .965)。
- 预设亚组分析中,异基因造血干细胞移植受者检出流感样病毒与更高的28天死亡率、IMV或两者复合结局相关。
证据类型、等级与局限
- 证据类型:随机对照试验的预设事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在免疫功能低下急性呼吸衰竭患者中,鼻咽多重PCR结果与IMV或死亡率无关,不应单独依据PCR阳性判断预后。
- PCR阳性患者中最终诊断病毒性肺炎者占三分之一,流感样病毒阳性者中占一半,提示需结合临床综合判断病因。
- 异基因造血干细胞移植受者检出流感样病毒可能与更高的28天死亡率、IMV或两者复合结局相关(预设亚组分析)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In immunocompromised patients with acute respiratory failure (ARF), the clinical significance of respiratory virus detection in the nasopharynx remains uncertain.
RESEARCH QUESTION: Is viral detection in nasopharyngeal swabs associated with causes and outcomes of ARF in immunocompromised patients?
STUDY DESIGN AND METHODS: This preplanned post hoc analysis of a randomized controlled trial enrolled immunocompromised patients admitted to 32 ICUs for ARF between May 2016 and December 2017. Nasopharyngeal swabs sampled at inclusion were assessed for 23 respiratory pathogens using multiplex polymerase chain reaction (PCR) assay. Causes of ARF were established by managing physicians and were reviewed by three expert investigators masked to the multiplex PCR assay results. Associations between virus detection in nasopharyngeal swabs, causes of ARF, and composite outcome of day 28 mortality, invasive mechanical ventilation (IMV), or both were assessed.
RESULTS: Among the 510 sampled patients, the multiplex PCR assay results were positive in 103 patients (20.2%), and a virus was detected in 102 samples: rhinoviruses or enteroviruses in 35.5%, coronaviruses in 10.9%, and flu-like viruses (influenza virus, parainfluenza virus, respiratory syncytial virus, human metapneumovirus) in 52.7%. The cause of ARF varied significantly according to the results of the multiplex PCR assay, especially the proportion of viral pneumonia: 50.0% with flu-like viruses, 14.0% with other viruses, and 3.6% when no virus was detected (P < .001). No difference was found in the composite outcome of day 28 mortality, IMV, or both according to positive assay findings (54.9% vs 54.7%; P = .965). In a pre-established subgroup analysis, flu-like virus detection was associated with a higher rate of day 28 mortality, IMV, or both among recipients of allogeneic hematopoietic stem cell transplantation compared with those without detected virus.
INTERPRETATION: In immunocompromised patients with ARF, the results of nasopharyngeal multiplex PCR assays are not associated with IMV or mortality. A final diagnosis of viral pneumonia is retained in one-third of patients with positive assay results and in one-half of the patients with a flu-like virus.
参考来源
- Maillard A, Le Goff J, Barry M, et al. Multiplex Polymerase Chain Reaction Assay to Detect Nasopharyngeal Viruses in Immunocompromised Patients With Acute Respiratory Failure. Chest. 2023. PMID: 37567412. doi:10.1016/j.chest.2023.07.4222
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。